PACS Group is trading 5% up today at $47.05 after reporting strong second-quarter results and raising its financial outlook.

  • Revenue grew 9.1% year-over-year to $1.43 billion, supported by increased EPS and a lift in full-year revenue and Adjusted EBITDA guidance.
  • Management expressed confidence in continued growth, specifically highlighting an improved outlook through 2026.
  • The stock's performance is further bolstered by a broadly positive healthcare sector and favorable wider market conditions.